COPROCESSOR EXCIPIENTS PDF

Stephen T. Chang has filed for patents to protect the following inventions. Justia Patents Stephen T. Stabilized liquid anti-RSV antibody formulations. Patent number:

Author:Mazutaur Arashilmaran
Country:Chad
Language:English (Spanish)
Genre:Personal Growth
Published (Last):18 April 2006
Pages:430
PDF File Size:18.48 Mb
ePub File Size:3.50 Mb
ISBN:744-3-25482-538-4
Downloads:41851
Price:Free* [*Free Regsitration Required]
Uploader:Faukus



Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more. You simply add your active ingredient, a lubricant, and compress your tablets. It is that easy. The excipient is based on extensive research and development, aimed at creating excipients that enable faster, more efficient manufacturing — while delivering perfect results every time. Together, they form a granulate with excellent flowability, low hygroscopicity, plus outstanding binding power.

This enables you to quickly and easily create homogeneous mixtures with your active ingredient, and to directly compress high-quality tablets. All components comply with the leading pharmacopoeias — giving you guaranteed quality from the very outset. You no longer have to weigh individual components, and blend them yourself. Add your lubricant, and compress your tablets. It is as easy as that. Although manufactured by direct compression , the tablets demonstrate exceptionally low friability.

And giving you peace of mind: because you know you can be sure of great results, each and every time. Direct compression DC is the most economic way to produce a tablet as it is the shortest and most direct way to get from powder mix to final dosage form. BASF offers all functional excipients to successfully develop a DC process for your drug, including key elements like appropriate binder and lubricant. Dry granulation is a great choice to produce solid oral dosage forms if cost and process efficiency are essiential.

BASF offers the most effective dry binders available, along with all other functional materials and expertise required to help you develop your process successfully. Orally disintegrating tablets ODT , are an innovative solid oral dosage form that is becoming more and more important in the pharmaceutical market, both for prescription and over-the-counter medications.

In contrast to classical tablets, ODTs are specifically designed to disintegrate directly in the patient's mouth. BASFs rich portfolio of instant and modified release solutions offers an unprecedented range of functionality. What makes Ludipress so effective? Applications The main application is for direct compression , but is also suitable as a filler for hard gelatine capsules. Cut development time.

Reduced process steps. The ideal mixture. Ultra-fast disintegration. Fast release of active ingredients. This is illustrated by the results gained with a Glibenclamid formulation. The unique composition of Ludipress yields tablets with excellent hardness and compression properties.

Portfolio Overview Focusing on your needs with platform solutions. Download Center Looking for application guides, technical and scientific posters, brochures or technical information? Visit our Download Center. Related Process Technologies. Direct Compression Direct compression DC is the most economic way to produce a tablet as it is the shortest and most direct way to get from powder mix to final dosage form.

Dry Granulation Dry granulation is a great choice to produce solid oral dosage forms if cost and process efficiency are essiential.

Related Special Applications. Orally Disintegrating Tablets ODT Orally disintegrating tablets ODT , are an innovative solid oral dosage form that is becoming more and more important in the pharmaceutical market, both for prescription and over-the-counter medications. Related Solution Platforms. The main application is for direct compression , but is also suitable as a filler for hard gelatine capsules.

ALTRONIX EBRIDGE PDF

FORMULATION AND EVALUATION OF CHEWABLE TABLETS OF IBUPROFEN USING COPROCESSED EXCIPIENTS

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more. You simply add your active ingredient, a lubricant, and compress your tablets. It is that easy. The excipient is based on extensive research and development, aimed at creating excipients that enable faster, more efficient manufacturing — while delivering perfect results every time.

BUSCANDO AMIGOS ENTRE ENEMIGOS PANCHO VILLA Y LOS MORMONES PDF

US20150150938A1 - Pharmaceutical formulations - Google Patents

The present invention relates to a composition useful as a pharmaceutical excipient material, characterized by microcrystalline celolusa and calcium carbonate coprocessed particulate present the two components in the ratio by weight of to microcrystalline cellulose: carbonate calcium. A process for preparing a material useful as a pharmaceutical excipient particles comprising forming an aqueous slurry well dispersed microcrystalline cellulose and calcium carbonate, both being present in particulate form and in amounts which produce a component ratio within the limits specified down to the product coprocessed particulate and drying the aqueous slurry to the removal of the same water to give a coprocessed particulate product, wherein the ratio by weight of microcrystalline cellulose are compared to calcium carbonate is within the limits of from to USA true EPB1 en. JPHB2 en. ARA1 en.

Related Articles